Literature DB >> 16645584

Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.

Giorgia Randi1, Luigi Naldi, Silvano Gallus, Anna Di Landro, Carlo La Vecchia.   

Abstract

The risk of cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi. Scanty information is available on the association between CMM at a specific anatomical site and number of nevi at the same site. We analyzed data from a case-control study conducted in Italy between 1992 and 1994, on 542 cases of CMM and 538 hospital controls. Cases and controls were examined by trained dermatologists who counted the number of melanocytic nevi. We derived multivariate odds ratios (ORs) and 95% confidence intervals (95% CIs) of site-specific risk of CMM for high versus low number of nevi at the corresponding site. The ORs of CMM for the highest versus the lowest tertile of number of nevi at the corresponding site was 1.4 (95% CIs: 0.7-2.8) at face and neck, 2.3 (95% CIs: 1.1-4.9) at anterior trunk, 4.9 (95% CIs: 2.9-8.4) at posterior trunk, 2.9 (95% CIs: 1.2-6.6) at upper limbs and 5.0 (95% CIs: 2.9-8.5) at lower limbs. In a case-case analysis, comparing CMM cases at a specific site and CMM cases at all other sites, the only excess risk was found for the posterior trunk, the ORs being 2.1 (95% CIs: 1.2-3.6) for the highest versus the lowest tertile of number of nevi. Our data do not support the hypothesis of a specific effect of nevi at each single anatomical site.

Entities:  

Mesh:

Year:  2006        PMID: 16645584     DOI: 10.1038/sj.jid.5700334

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.

Authors:  Reza Ghiasvand; Trude E Robsahm; Adele C Green; Corina S Rueegg; Elisabete Weiderpass; Eiliv Lund; Marit B Veierød
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis.

Authors:  Catherine M Olsen; Michael S Zens; Adele C Green; Therese A Stukel; C D'Arcy J Holman; Thomas Mack; J Mark Elwood; Elizabeth A Holly; Carlotta Sacerdote; Richard Gallagher; Anthony J Swerdlow; Bruce K Armstrong; Stefano Rosso; Connie Kirkpatrick; Roberto Zanetti; Julia Newton Bishop; Veronique Bataille; Yu-Mei Chang; Rona Mackie; Anne Østerlind; Marianne Berwick; Margaret R Karagas; David C Whiteman
Journal:  Int J Cancer       Date:  2010-11-16       Impact factor: 7.396

Review 3.  Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review.

Authors:  Dilki Jayasinghe; Kaitlin L Nufer; Brigid Betz-Stablein; H Peter Soyer; Monika Janda
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-30

4.  Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.

Authors:  Zhen Zhen Zhao; David L Duffy; Shane A Thomas; Nicholas G Martin; Nicholas K Hayward; Grant W Montgomery
Journal:  Melanoma Res       Date:  2009-04       Impact factor: 3.599

5.  Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.

Authors:  Catherine M Olsen; Michael S Zens; Therese A Stukel; Carlotta Sacerdote; Yu-Mei Chang; Bruce K Armstrong; Veronique Bataille; Marianne Berwick; J Mark Elwood; Elizabeth A Holly; Connie Kirkpatrick; Thomas Mack; Julia Newton Bishop; Anne Østerlind; Anthony J Swerdlow; Roberto Zanetti; Adèle C Green; Margaret R Karagas; David C Whiteman
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

6.  The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado.

Authors:  Ashley L Juhl; Tim E Byers; William A Robinson; Joseph G Morelli; Lori A Crane
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

7.  Cutaneous melanoma primary site is linked to nevus density.

Authors:  Alejandro Martin-Gorgojo; Marta Llinares; Amaya Virós; Celia Requena; Zaida Garcia-Casado; Víctor Traves; Rajiv Kumar; Eduardo Nagore
Journal:  Oncotarget       Date:  2017-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.